PubMed

Surrogate end points in clinical trials: are we being misled?

Fleming TR, DeMets DL.

Ann Intern Med. 1996 Oct 1;125(7):605-13. Review. No abstract available. PMID: 8815760 [PubMed - indexed for MEDLINE]Related articlesFree article

"Sufficient life expectancy": an amazing inclusion criterion in cancer phase II-III trials.

Penel N, Clisant S, Lefebvre JL, Adenis A.

J Clin Oncol. 2009 Sep 10;27(26):e105. Epub 2009 Aug 10. No abstract available. PMID: 19667257 [PubMed - indexed for MEDLINE]Related articles

Interim analyses in clinical trials: why do we plan them?

Fossâ SD, Skovlund E.

J Clin Oncol. 2000 Dec 15;18(24):4007-8. No abstract available. PMID: 11118460 [PubMed - indexed for MEDLINE]Related articles

[Surrogate endpoints]

Hill C.

Bull Cancer. 1999 Jul-Aug;86(7-8):622-4. French. PMID: 10477379 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomized, controlled clinical trials in sepsis: has methodological quality improved over time?

Graf J, Doig GS, Cook DJ, Vincent JL, Sibbald WJ.

Crit Care Med. 2002 Feb;30(2):461-72. Review.PMID: 11889331 [PubMed - indexed for MEDLINE]Related articles

Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.

Sarzotti-Kelsoe M, Cox J, Cleland N, Denny T, Hural J, Needham L, Ozaki D, Rodriguez-Chavez IR, Stevens G, Stiles T, Tarragona-Fiol T, Simkins A.

PLoS Med. 2009 May 26;6(5):e1000067. Epub 2009 May 5. No abstract available. PMID: 19536325 [PubMed - indexed for MEDLINE]Related articlesFree article

[Methodological approaches of clinical studies with targeted therapies]

Penel N, Saleron J, Lansiaux A, Clisant S, Adenis A, Fournier C, Duhamel A, Bonneterre J.

Bull Cancer. 2008 Feb;95(2):185-90. Review. French. PMID: 18304903 [PubMed - indexed for MEDLINE]Related articles

New proposed guidelines for clinical trials in liver cancer.

Lang L.

Gastroenterology. 2008 Jul;135(1):7. Epub 2008 Jun 11. No abstract available. PMID: 18554512 [PubMed - indexed for MEDLINE]Related articles

[Can the correct dose be predicted by phase III?]

Dahan R, Jaillon P, Lehner JP.

Therapie. 1993 Jul-Aug;48(4):297-301. French. No abstract available. PMID: 7907438 [PubMed - indexed for MEDLINE]Related articles

Examining heterogeneity in phase II trial designs may improve success in phase III.

Tuma RS.

J Natl Cancer Inst. 2008 Feb 6;100(3):164-6. Epub 2008 Jan 29. No abstract available. PMID: 18230788 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of predictive probabilities in phase II and phase III clinical trials.

Johns D, Andersen JS.

J Biopharm Stat. 1999 Mar;9(1):67-79.PMID: 10091910 [PubMed - indexed for MEDLINE]Related articles

Novel endpoints and design of early clinical trials.

Parulekar WR, Eisenhauer EA.

Ann Oncol. 2002;13 Suppl 4:139-43. Review. No abstract available. PMID: 12401680 [PubMed - indexed for MEDLINE]Related articlesFree article

An overview of clinical trials.

Rich K.

J Vasc Nurs. 2004 Mar;22(1):32-4. Review. No abstract available. PMID: 14981501 [PubMed - indexed for MEDLINE]Related articles

Clinical trials.

Farrington P, Miller E.

Methods Mol Med. 2003;87:335-52. No abstract available. PMID: 12958466 [PubMed - indexed for MEDLINE]Related articles

Quality of life in clinical cancer trials: experience and perspective of the European Organization for Research and Treatment of Cancer.

Kiebert GM, Kaasa S.

J Natl Cancer Inst Monogr. 1996;(20):91-5. No abstract available. PMID: 8750477 [PubMed - indexed for MEDLINE]Related articles

Accelerated drug development through combined phase 2/3 clinical trial design.

Cunningham ET Jr, da Silva L, Harrison EM, Modi MW, O'Shaughnessy D, Guyer DR.

Arch Ophthalmol. 2004 Jul;122(7):1043-4. No abstract available. PMID: 15249371 [PubMed - indexed for MEDLINE]Related articles

Clinical trials referral resource. Current phase II and phase III clinical trials in the treatment of colorectal cancer.

Mooney MM, Schoenfeldt M.

Oncology (Williston Park). 2004 Oct;18(11):1396, 1401, 1404 passim. No abstract available. PMID: 15609469 [PubMed - indexed for MEDLINE]Related articles

The phase II/III transition. Toward the proof of efficacy in cancer clinical trials.

Fazzari M, Heller G, Scher HI.

Control Clin Trials. 2000 Aug;21(4):360-8.PMID: 10913810 [PubMed - indexed for MEDLINE]Related articles

Standardization, more funds on horizon for clinical trials.

McNeil C.

J Natl Cancer Inst. 2005 Apr 20;97(8):555-7. No abstract available. PMID: 15840874 [PubMed - indexed for MEDLINE]Related articlesFree article

Does the Prentice criterion validate surrogate endpoints?

Berger VW.

Stat Med. 2004 May 30;23(10):1571-8.PMID: 15122737 [PubMed - indexed for MEDLINE]Related articles